DE SIMONE, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 24.835
AS - Asia 13.872
EU - Europa 7.403
SA - Sud America 3.460
AF - Africa 534
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 18
Totale 50.140
Nazione #
US - Stati Uniti d'America 23.903
SG - Singapore 4.401
CN - Cina 3.502
HK - Hong Kong 3.395
BR - Brasile 2.870
IT - Italia 2.348
BG - Bulgaria 1.318
VN - Vietnam 1.280
SE - Svezia 873
CA - Canada 780
DE - Germania 672
RU - Federazione Russa 587
TR - Turchia 431
GB - Regno Unito 407
AR - Argentina 253
AT - Austria 233
CI - Costa d'Avorio 170
FI - Finlandia 163
IN - India 155
FR - Francia 139
UA - Ucraina 136
SN - Senegal 113
BD - Bangladesh 106
PL - Polonia 97
EC - Ecuador 96
MX - Messico 85
ID - Indonesia 83
ES - Italia 81
ZA - Sudafrica 76
JP - Giappone 74
KR - Corea 74
IQ - Iraq 61
CH - Svizzera 59
CO - Colombia 59
NL - Olanda 54
MA - Marocco 49
PY - Paraguay 49
EE - Estonia 47
UZ - Uzbekistan 43
UY - Uruguay 41
EG - Egitto 40
PK - Pakistan 39
BE - Belgio 34
SA - Arabia Saudita 34
CL - Cile 28
CZ - Repubblica Ceca 28
VE - Venezuela 28
PE - Perù 25
IR - Iran 20
IE - Irlanda 17
KE - Kenya 17
TN - Tunisia 17
NP - Nepal 16
PH - Filippine 16
LT - Lituania 15
RO - Romania 15
AZ - Azerbaigian 14
AE - Emirati Arabi Uniti 13
DO - Repubblica Dominicana 13
PS - Palestinian Territory 13
AU - Australia 12
KZ - Kazakistan 11
MD - Moldavia 11
NG - Nigeria 11
PT - Portogallo 11
TW - Taiwan 11
BO - Bolivia 10
DZ - Algeria 10
EU - Europa 9
JO - Giordania 9
MY - Malesia 9
BJ - Benin 8
ET - Etiopia 8
GR - Grecia 8
OM - Oman 8
TT - Trinidad e Tobago 8
AL - Albania 7
GE - Georgia 7
HN - Honduras 7
LB - Libano 7
RS - Serbia 7
GT - Guatemala 6
HU - Ungheria 6
IL - Israele 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
BZ - Belize 5
JM - Giamaica 5
KG - Kirghizistan 5
LK - Sri Lanka 5
SI - Slovenia 5
BB - Barbados 4
BN - Brunei Darussalam 4
CR - Costa Rica 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
A1 - Anonimo 3
BA - Bosnia-Erzegovina 3
Totale 50.084
Città #
Hong Kong 3.377
Woodbridge 2.933
Ashburn 2.642
Singapore 2.240
Houston 2.043
Fairfield 2.020
Dallas 1.663
Sofia 1.314
Chandler 1.062
Shanghai 1.059
Ann Arbor 1.031
Serra 881
Beijing 869
Santa Clara 842
Seattle 842
Princeton 733
New York 715
Wilmington 706
Ottawa 697
Cambridge 688
Boardman 545
Lawrence 490
Medford 460
Milan 422
Des Moines 407
Los Angeles 387
Istanbul 319
Ho Chi Minh City 313
Redondo Beach 260
Nanjing 221
Buffalo 216
São Paulo 204
Florence 190
Vienna 187
Hanoi 182
Munich 177
Abidjan 168
Dong Ket 140
Jacksonville 129
Dearborn 127
London 126
Pisa 121
Dakar 112
San Diego 112
Ogden 106
Hefei 97
Rio de Janeiro 89
Nanchang 88
Warsaw 87
Shenyang 81
Frankfurt am Main 80
Boulder 76
Changsha 67
Tokyo 64
Izmir 63
Hebei 61
Redwood City 59
Seoul 58
Belo Horizonte 57
Turku 52
Brasília 51
Rome 50
Stockholm 46
Nuremberg 45
San Jose 44
Grafing 43
Kunming 43
Norwalk 43
Porto Alegre 43
Council Bluffs 42
Curitiba 42
Fuzhou 42
Haiphong 42
Tallinn 42
Bern 41
Chicago 40
Paris 40
Guangzhou 39
The Dalles 39
Falls Church 38
Johannesburg 37
Montevideo 37
Tashkent 37
Jiaxing 35
Columbus 34
Guayaquil 34
Tianjin 34
Campinas 32
Guarulhos 32
Montreal 32
Quanzhou 32
Casablanca 31
Phoenix 31
Ribeirão Preto 30
Boston 29
Brooklyn 29
Dhaka 29
Brussels 28
Biên Hòa 27
Bremen 27
Totale 37.049
Nome #
Modification of immunosuppressive therapy as risk factor for complications after liver transplantation. 225
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes 222
Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. 220
The Tuscany model of a regional transplantation service authority: Organizzazione Toscana Trapianti 218
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 218
Use of Elderly Donors in Liver Transplantation: A Paired-match Analysis at a Single Center 210
Cost analysis of tumor downsizing for hepatocellular carcinoma liver transplant candidates 199
Circulating gamma-glutamyltransferase fractions in cirrhosis 198
Open-source as an enabling approach for the introduction of artificial intelligence in healthcare 194
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: The role of extracorporeal photopheresis 193
Severe liver trauma: the transplant surgeon's perspective. A case report 192
Perfusion machines and hepatocellular carcinoma: A good match between a marginal organ and an advanced disease? 190
Multi-locular thymic cysts after acute pancreatitis in a liver transplant recipient 187
Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: A pilot study. 186
Functional and survival analysis of isolated human islets 182
Anti-inflammatory Signaling During Ex Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation 182
Increased FNDC5/Irisin expression in human hepatocellular carcinoma. 182
Adie tonic pupil associated to endometriosis 181
Aortic valve-sparing procedure—a durable choice in liver transplantation recipient 179
Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia 178
Dual aortic and portal perfusion at procurement prevents ischaemic-type biliary lesions in liver transplantation when using octogenarian donors: a retrospective cohort study. 178
Ex vivo efficacy demonstration of a laser fenestration system for endovascular abdominal aortic aneurysm repair (EVAR) 177
Posttransplant hepatocellular carcinoma metastasis at a skull trauma site 176
Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature 176
FAILURE OF ENDOSCOPY FOR NONANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION 173
ENDOSCOPIC MANAGEMENT OF POST-LIVER TRANSPLANT BILIARY COMPLICATIONS: OUTCOME ANALYSIS OF 751 PROCEDURES 172
Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery 171
The impact of everolimus on renal function in maintenance liver transplantation 171
Interregional allocation models for liver transplantation 171
Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation. 170
The quality assurance program of organ donation in Tuscany 169
The epidemiology of brain death in Tuscany: is there need for novel indicators? 168
Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease? 168
Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes 165
Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. 164
Esofagomiotomia laparoscopica nel trattamento dell’acalasia esofagea. 163
Quality assurance, efficiency indicators and cost-utility of the evaluation workup for liver transplantation 162
COMMON POLYMORPHISM IN THE MCP-1 GENE REGULATORY REGION INFLUENCES MCP-1 EXPRESSION AND FUNCTION OF ISOLATED TYPE 2 PANCREATIC ISLETS 162
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 161
Salvage of an octogenarian liver graft using normothermic perfusion. A case report 160
In situ diode laser fenestration: An ex-vivo evaluation of irradiation effects on human aortic tissue 160
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 159
Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - Findings from the International BRIGHT Study. 159
Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study 159
Avoiding calcineurin inhibitors in the early post-operative course in high-risk liver transplant recipients: Preliminary results of the protect trial 158
Multi-layer nanoencapsulation of human pancreatic islets 157
The "You Are Not Alone" care program for liver transplantation 156
AVOIDING CALCINEURIN INHIBITORS IN THE EARLY POST-OPERATIVE COURSE IN HIGH-RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 155
Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study. 155
Transplant nursing: scope and standards of practice 154
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 151
AVOIDING CALINEURIN INHIBITORS IN THE EARLY POST OPERATIVE COURSE IN HIGH RISK LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS OF THE PROTECT TRIAL 149
A selective policy of tumor down staging helps improve the results of liver transplantation for HCC patients within the Milan criteria 149
Involvement of the receptor for advanced glycation end products in liver transplantation 147
2018 Annual Report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation 147
A common polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene regulatory region influences MCP-1 expression and function of isolated human pancreatic islets 146
null 146
Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation 146
A non-meld based allocation algorithm for HCC patients undergoing liver transplantation allows favorable results: The Tuscany experience 145
Atypical acute leukemia early after liver transplantation 144
Refusal to donate after brain death 143
Combined or staged liver transplantation and duodeno-pancreasectomy: Indications,complications and expansion of wait list criteria 142
Aminopyrine breath test in cirrhotic patients awaiting liver transplantation: do we really need it ? 141
Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting. 141
Nonagenarian Grafts for Liver Transplantation 141
Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution 141
What is the role of the receptor for advanced glycation endproducts-ligand axis in liver injury? 139
Strategies to optimize the use of marginal donors in liver transplantation. 138
Post-transplant liver graft schistosomiasis in a migrant from sub-saharan africa. 138
The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: Findings from the cross-sectional BRIGHT study. 137
THE PARADOX OF ORGAN SHORTAGE AND EQUITY: HOW TO SOLVE THE RIDDLE ? 136
Efficiency of the Tissue Procurement Process: What Evaluation Tools? 135
COVID-19 infection requires strengthening of the chronic care model: the impact on liver transplant practice at a high-volume center in Italy 135
A common polymorphism in the MCP-1 gene regulatory regioninfluences MCP-1 expression and function of isolated Type 2 pancreatic islets 134
The organizational model of the interregional transplant agency Organizzazione Centro-Sud Trapianti. 134
Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors 134
Patient satisfaction among liver transplant recipients: single-center survey. 133
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients 132
A model for southern mediterranean research institute self-assessment: A SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt 132
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs. 132
An Unexpected Case of Opisthorchis felineus Infection Revealed during Liver Transplantation 131
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 131
Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study 130
Lower level of care adversely impacts the outcome of liver transplantation 130
7-T MRI of explanted liver and ex-vivo pancreatic specimens: prospective study protocol of radiological-pathological correlation feasibility (the EXLIPSE project) 130
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma 130
A model for Southern Mediterranean research institute self-assessment: a SWOT analysis-based approach to promote capacity building at Theodor Bilharz Research Institute in Cairo (Egypt). 129
Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. 128
Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome 128
Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation 127
Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients. 127
Liver transplantation in type III von Willebrand disease 127
Liver transplantation with aged donors in patients with hepatitis C virus: Authors' reply 126
EVEROLIMUS-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A REDUCED RISK OF NEW- ONSET MALIGNANCIES AFTER LIVER TRANSPLANTATION 126
A NOVEL APPROACH TO ALLOGRAFT REJECTION IN LIVER TRANSPLANT PATIENTS: EXTRACORPOREAL PHOTOPHERESIS 125
Donor diabetes and prolonged cold ischemia time increase the risk of graft failure after liver transplant: Should we need a redefinition of the donor risk index? 125
Successful Transplant of a Nonagenarian Liver Graft With Fully Replaced Right Hepatic Artery Reconstruction. 125
Tissue procurement and transplantation: a Tuscany perspective 125
Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair 125
Immunoadsorption with protein A in humoral rejection of kidney transplants. 124
Totale 15.642
Categoria #
all - tutte 151.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.669 0 0 0 0 0 122 110 140 241 170 385 501
2021/20224.746 39 341 65 207 940 691 99 236 244 110 170 1.604
2022/20233.794 648 451 219 276 393 511 40 266 650 21 279 40
2023/20243.162 229 335 273 204 500 583 126 91 134 57 133 497
2024/202512.775 86 584 103 790 760 1.109 1.170 931 1.458 1.972 1.440 2.372
2025/202610.440 642 1.926 2.524 2.492 1.424 1.432 0 0 0 0 0 0
Totale 50.669